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Abstract
AIM
To investigate the role of contrast enhanced ultrasound 
(CEUS) in evaluating patients with renal function im-
pairment (RFI) showing: (1) acute renal failure (ARF) of 
suspicious vascular origin; or (2) suspicious renal lesions.
METHODS
We retrospectively evaluated patients addressed to CEUS 
over an eight years period to rule-out vascular causes of 
ARF (first group of 50 subjects) or assess previously found 
suspicious renal lesions (second group of 41 subjects with 
acute or chronic RFI). After preliminary grey-scale and 
color Doppler investigation, each kidney was investigated 
individually with CEUS, using 1.2-2.4 mL of a sulfur 
hexafluoride-filled microbubble contrast agent. Image 
analysis was performed in consensus by two readers who 
reviewed digital clips of CEUS. We calculated the detection 
rate of vascular abnormalities in the first group and 
performed descriptive statistics of imaging findings for the 
second group.
RESULTS
In the first group, CEUS detected renal infarction or 
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cortical ischemia in 18/50 patients (36%; 95%CI: 
23.3-50.9) and 1/50 patients (2%; 95%CI: 0.1-12), 
respectively. The detection rate of infarction was sig-
nificantly higher (P  = 0.0002; McNemar test) compared to 
color Doppler ultrasonography (10%). No vascular causes 
of ARF were identified in the remaining 31/50 patients 
(62%). In the second group, CEUS detected 41 lesions 
on 39 patients, allowing differentiation between solid 
lesions (21/41; 51.2%) vs  complex cysts (20/41; 48.8%), 
and properly addressing 15/39 patients to intervention 
when feasible based on clinical conditions (surgery and 
cryoablation in 13 and 2 cases, respectively). Cysts were 
categorized Bosniak Ⅱ, ⅡF, Ⅲ and Ⅳ in 8, 5, 4 and 3 
cases, respectively. In the remaining two patients, CEUS 
found 1 pseudolesion and 1 subcapsular hematoma. 
CONCLUSION
CEUS showed high detection rate of renal perfusion 
abnormalities in patients with ARF, influencing the 
management of patients with acute or chronic RFI and 
renal masses throughout their proper characterization.
Key words: Contrast-enhanced ultrasonography; Renal 
function impairment; Acute renal failure; Renal infarction; 
Renal lesions; Renal cysts; Bosniak classification
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Core tip: Imaging in patients with renal function im-
pairment (RFI) is challenging because of well-known 
limitations of conventional color Doppler ultrasound or 
risks related to the use of contrast media on computed 
tomography and magnetic resonance imaging. Contrast-
enhanced ultrasound is a safer imaging tool in patients 
with RFI, showing 36% detection rate of renal infarction 
in patients with acute renal failure of suspicious vascular 
origin, and the capability of characterizing renal lesions in 
order to address patients to most proper treatment.
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URL: http://www.wjgnet.com/1949-8470/full/v9/i1/10.htm  DOI: 
http://dx.doi.org/10.4329/wjr.v9.i1.10
INTRODUCTION
Despite technical improvements, imaging of patients 
with renal function impairment (RFI) is challenging. 
Contrast-enhanced computed tomography (CT) and 
magnetic resonance imaging (MRI) provide panoramic 
representation of the kidneys, perirenal spaces, and 
vessels, leading to high diagnostic accuracy. However, 
iodinated contrast agents are potentially harmful in 
patients with RFI because of the risk of contrast-induced 
nephropathy (CIN)[1]. Although risk for nephrogenic 
systemic fibrosis (NSF) has been better defined over the 
last years, concerns still exist for the use of gadolinium 
chelates in patients with RFI, given uncertainty in patho-
genic mechanisms and/or potential additional side effects 
related to gadolinium accumulation in the brain[1-4]. 
In practice, it is recommended to consider alternative 
imaging modalities in patients at risk with the use of 
iodinated or gadolinium contrast media[1].
Color-Doppler ultrasound (US) is the first imaging 
modality in patients with RFI. It is widely used to rule-out 
obstruction or investigate renal vessels and parenchymal 
abnormalities without the use of nephrotoxic agents[5]. 
In addition, US permits the detection of incidental, 
otherwise unknown renal lesions. However, there are 
well-known limitations of conventional Doppler modes in 
evaluating these patients, including difficult detection of 
perfusion abnormalities in globally hypoperfused kidneys, 
and unreliable characterization of renal masses other 
than simple cysts[5-8]. In particular, conventional Doppler 
modes do not allow differentiation between hypovascular 
tumors and complicated cysts[9,10], both of common 
occurrence in patients with RFI, nor can reliably assess 
the risk of malignancy of complex cystic masses.
Contrast-enhanced ultrasound (CEUS) has been 
advocated as the imaging modality of choice to evaluate 
patients with RFI, given the absence of nephrotoxicity 
and the ability of representing renal vascularization 
with excellent sensitivity and high spatial resolution[9,11]. 
According to the European federation of societies for 
ultrasound in medicine and biology (EFSUMB) guidelines, 
imaging with CEUS should be considered in every patient 
with RFI, when able to provide the clinically necessary 
information[1]. CEUS has the potential to compensate 
for limitations of conventional Doppler modes with 
a diagnostic performance comparable or superior to 
CT in the detection of perfusion abnormalities, lesion 
characterization (cystic vs solid), and categorization 
of cysts according to Bosniak criteria[10,12-14]. To our 
knowledge, however, evidence supporting the above 
indications results from reports on patients with normal 
renal function and experts opinion rather than specifically 
addressed studies, which currently lack. 
The purpose of this study was to investigate the role 
of CEUS in a population of patients with RFI to assess 
the cause of renal function deterioration when perfusion 




Referring institutional review board approved this study 
and waived for informed consent acquisition due to the 
retrospective design, in accordance with regulations 
of our country. By performing a computer search, we 
identified all patients with RFI who underwent renal 
CEUS over an 8-years period (January 2004-August 
2012) to assess the cause of renal function deterioration, 
or to attempt characterization of renal masses. Patients 
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of the first group were investigated to rule-out a vascular 
cause for renal function deterioration. They were patients 
with risk factors for renal infarction manifesting a rapid 
decline of the estimated glomerular filtration rate (eGFR). 
In this group, conventional Doppler modes were used to 
investigate the renal arteries and parenchymal vessels, 
while CEUS was subsequently performed to rule-out 
infarcted areas not identified with conventional modes. 
Patients of the second group had renal masses identified 
on previous conventional US or unenhanced CT. All of 
them showed eGFR < 60 mL/min per 1.73 m2 estimated 
from the serum creatinine values using the CKD-EPI 
equation[15]. Renal impairment was scored according 
to the grades of the National Kidney Foundation[16]. We 
assessed RFI according to the Kidney disease improving 
global outcomes (KDIGO) criteria for both acute renal 
failure (ARF)[17] and chronic renal failure (CRF)[18].
A total of 91 patients were enrolled (64 men, 27 
women; age range 40-88 years; mean age 71.4 ± 11.02 
years), showing renal impairment ranging from grade 3 
to grade 5. Indications to CEUS were: (1) assessment 
of renal function deterioration in 50/91 patients; and (2) 
characterization of focal renal lesions in the remaining 
41/91 patients.
CEUS technique
CEUS was performed using different ultrasound equip-
ment and contrast-specific modes (Table 1). After 
preliminary grey-scale and color Doppler investigation, 
CEUS examination was set with low acoustic power to 
achieve minimum microbubble destruction (mechanical 
index between 0.06 and 0.2, depending on the equipment 
used). Each kidney was evaluated separately after i.v. 
injection of a 1.2-2.4 mL dose of a sulfur hexafluoride-
filled microbubble contrast agent (SonoVue, BR1, Bracco, 
Milan, Italy). A 20-gauge cannula was used for contrast 
injection, followed by a 10 mL normal saline flush. Digital 
cine-clips were acquired to allow for post-procedure re-
evaluation.
Image analysis
One radiologist with 18 years of experience in CEUS 
performed all the examinations. For the purpose of 
the study, he and a junior radiologist with five years of 
experience in this technique reviewed in consensus the 
images of conventional Doppler modes and the cine-
clips of entire CEUS examinations, using a commercially 
available display workstation (OsiriX MD v.7.5, Pixmeo, 
Bernex, CH). Readers were blinded to histological 
diagnosis and/or follow-up results. No discrepancies 
were found between image interpretation at the time of 
examinations and during study review. Readers were asked 
to assess the presence of renal infarctions, characterize 
renal lesions as solid or cystic, and classify those with 
cystic appearance at CEUS according to the Bosniak 
criteria. 
Readers assessed renal infarction on conventional 
Doppler modes in presence of parenchymal regions 
lacking color signal[19]. Concerning CEUS, we used the 
following diagnostic criteria: (1) infarction was diagnosed 
in presence of at least one well-defined, wedge-sha-
ped non-enhancing area within an otherwise normal-
appearing kidney[12]; (2) cortical ischemia was diagnosed 
in presence of enhancing interlobar and arcuate arteries 
with non-enhancing portions of the cortex[11]; and (3) 
a lesion was considered solid if more than half of the 
volume was represented by enhancing solid tissue, 
and cystic if composed predominantly of nonenhancing 
spaces[10,20]. Cystic lesions were graded according to the 
Bosniak criteria as previously described[13,14].
Data analysis
For the group of patients investigated to rule-out a 
vascular cause for renal function deterioration we cal-
culated the detection rate of vascular abnormalities 
[(number of positive cases/total number of cases) × 
100]. Analysis was performed on a per-patient basis 
by identifying at least one area of renal involvement. 
Significance of the difference between techniques in 
the detection rate of renal infarction was assessed with 
the McNemar test, using a reference alfa level of 0.01. 
Analysis was performed with a commercially available 
software (MedCalc v9.1, Mariakerke, Belgium). 
For the group of patients with suspicious renal 
lesions we performed descriptive statistics of CEUS 
findings on a per-lesion basis.
RESULTS
Patients with acute RFI of suspicious vascular origin
Of fifty patients, 38 were males and 12 females (mean 
age: 71 ± 9 years, range 40-88 years). They presented 
with ARF either in previously well-functioning kidneys 
(31/50, 62%; 95%CI: 47.2-75.0), or complicating an 
already known CRF (19/50, 38%; 95%CI: 25.0-32.8). 
Causes of ARF were established based on clinical 
history and imaging follow-up in 44/50 cases (88%), 
renal biopsy in 3/50 cases (6.0%) and autopsy in the 
Table 1  Sonographic equipment used in the study
Ultrasound equipment Contrast-specific mode No. of patients 
MyLab-70 (EsaOte) CnTI™ (contrast tuned imaging)   7
ATL HDI5000 (Philips) PIHI™ (pulse inversion harmonic imaging) 15
Sequoia 512 (Acuson Siemens) CPS™ (contrast pulse sequencing) 54
iU22 (Philips) PIHI-PM™ (pulse inversion harmonic imaging – power modulation) 15
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remaining 3/50 cases (6.0%). 
Renal infarction was found in 18/50 patients (36%; 
95%CI: 23.3-50.9) using CEUS and 5/50 (10%; 95%CI: 
3.7-22.6) using color Doppler US, corresponding to a 
significant difference in detection rate (P = 0.0002). 
In particular, CEUS found infarction in 13 additional 
subjects compared to color Doppler US (Figure 1). 
Moreover, CEUS identified acute cortical necrosis in one 
patient (2%; 95%CI: 0.1-12.0) presenting with non-
specific hypoperfusion of the kidneys at color Doppler 
interrogation (Figure 2). 
In the remaining 31/50 patients (62%; 95%CI: 
47.2-75.0), there was no evidence of vascular abnor-
malities both on color Doppler US and CEUS. Final 
presumptive diagnosis was reached in 20/31 patients 
based on clinical and laboratory features, course of 
the disease and kidney biopsy in three subjects (two 
with interstitial nephritis and one with atheroembolic 
renal disease, respectively). Other three patients with 
atheroembolic renal disease had positive skin biopsy. In 
the remaining 12 patients, the cause of renal function 
deterioration remained undetermined. CEUS findings, 
pre-existing renal function and final diagnosis are re-
ported in Table 2. 
Patients with renal lesions
Of 41 patients included in this group, 26 were male 
and 15 female (mean age: 70 ± 14 years, range 41-90 
years). CEUS showed a total of 41 lesions in 39 patients. 
Twenty-one/41 lesions were solid in nature (51.2%; 
95%CI: 35.4-66.8), whereas 20/41 lesions were 
assessed as complex cysts (48.8%; 95%CI: 33.2-64.6). 
Twelve out of 21 solid lesions were removed surgically, 
with final diagnosis of renal cancer, including 11 clear cell 
carcinomas (Figure 3) and 1 urothelial carcinoma. The 
remaining lesions included one oncocytoma diagnosed on 
autopsy, 7 indeterminate lesions addressed to imaging 
follow-up because of patients’ age and comorbidities 
contraindicating surgery, and one inoperable lesion 
addressed to angiographic embolization because of acute 
intratumoral hemorrhage.
Cysts were classified according to Bosniak categories 
Ⅱ, ⅡF, Ⅲ and Ⅳ in 8, 5, 4 and 3 cases, respectively. All 
category ⅡF lesions, 1/4 category Ⅲ and 1/3 category Ⅳ 
cysts remained stable over a 3-years imaging follow-up 
(Figure 4). Two category Ⅲ cysts were a papillary and a 
clear cell renal cell carcinoma (RCC) on biopsy performed 
before percutaneous cryoablation. One category Ⅳ lesion 
was a clear cell RCC at nephrectomy (Figure 5). The 
remaining two patients (one with category Ⅲ, one with 
category Ⅳ cysts) were not operated because of clinically 
relevant comorbidities. Lesions increased in size and 
complexity over time and were considered presumably 
malignant. The remaining two patients with suspicious 
renal tumor on conventional US had a pseudotumour 
Table 2  Overview of fifty patients with acute renal failure addressed to contrast-enhanced ultrasound to rule-out vascular causes
Findings on CEUS Side of CEUS findings Pre-existing renal function Cause of acute renal failure No. of patients with biopsy
Renal infarction (n = 
18)
Unilateral (n = 13)
Bilateral (n = 5)
Chronic RFI (n = 10)
No previous history of RFI (n = 8)
Suspicious embolization (n = 2)
Placement of aortic endoprothesis (n 
= 5)
Aortic dissection (n = 2)
Ischemia (n = 3)
Drug-induced nephrotoxicity (n = 1)
Undetermined (n = 5)
None
Acute cortical 
necrosis pattern (n = 
1)
Bilateral (n = 1) No previous history of RFI (n = 1) Post-surgical, hypovolemic acute 





None Chronic RFI (n = 21)
No previous history of RFI (n = 
10)
Atheroembolic disease (n = 10)
Acute pyelonephritis (n = 4)
Interstitial nephritis (n = 2) 
Acute papillary necrosis (n = 1)
Antiblastic drug-induced (n = 1)
Dehydration (n = 1)
Undetermined (n = 12)
1 kidney biopsy, 3 skin biopsy
2 kidney biopsy
CEUS: Contrast enhanced ultrasound; RFI: Renal function impairment.
Figure 1  Patient with solitary kidney developing acute renal failure. 
Contrast enhanced ultrasound showed multiple renal infarctions (arrows) 
involving a large portion of the parenchyma.
Girometti R et al . CEUS in patients with renal failure
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and a subcapsular hematoma at CEUS, respectively. 
DISCUSSION
Current EFSUMB guidelines recommend use of CEUS 
in patients with RFI[1]. Indeed, this technique can be 
performed during the same examination session of color 
Doppler US, thus acting as first-line and problem-solving 
imaging modality at the same time[9,11].
However, indication to CEUS in this scenario is based 
more on theoretical considerations and experts opinion 
than on results of validation studies. Indeed, the ability 
of CEUS to identify renal infarction and to characterize 
complex cystic masses, pseudolesions, and hypovascular 
lesions has been mostly demonstrated in patients with 
well-functioning kidneys[10,12,13,21]. To our knowledge, 
no specific studies focused on patients with renal fa-
ilure. Moreover, there is lack of evidence on whether 
information obtained with CEUS in patients with RFI 
has a clinical impact for patient management. 
Our results on a consecutive series of patients 
with renal failure investigated with CEUS show that 
this technique is effective in identifying renal infarction 
and characterizing renal masses. When a vascular 
cause for the deterioration of the renal function was 
suspected, CEUS either confirmed the diagnosis or, 
when negative, prompted further clinical workup and 
eventually identification of other causes of renal function 
deterioration. CEUS clearly outperformed US with color 
Doppler, with a significantly higher detection rate of 
renal infarction (36% vs 10%) (P = 0.0002). Moreover, 
CEUS was able to differentiate between renal infarctions 
and cortical ischemia, which showed no definite corres-
pondence on color Doppler US. Therefore, CEUS proved 
to be effective as problem solving technique in these 
patients, with the advantage of avoiding radiation 
Figure 2  Patient with grade III chronic renal 
failure developing acute renal failure after 
Endovascular aortic repair. A: Color Doppler 
ultrasound showed avascular kidney; B: Contrast 
enhanced ultrasound showed enhancing hilar 
vessels and lack of enhancement of large 
portions of the cortex (arrowheads) consistent 
with acute cortical necrosis. The contralateral 
kidney was normal (not shown).
Figure 3  Patient with grade III chronic renal 
failure. A: Color Doppler ultrasound showed 
markedly reduced renal parenchyma perfusion and 
a hypoechoic lesion without obvious vascularity 
(arrows); B: Contrast enhanced ultrasound showed 
a solid enhancing mass (arrows) with avascular 
central portion (1). A clear cell RCC with necrotic 
central areas was found at surgery. RCC: Renal 
cell carcinoma.1
Figure 4  Patient with grade IV chronic renal 
failure. A: Grey-scale ultrasound showed a 
complex renal lesion (arrows). Contrast enhanced 
ultrasound showed no intralesional enhancement, 
nor vegetations; B: Two thin septa were visible 
(arrowheads) with minimum enhancement (benign 
minimally complicated cysts, Bosniak category II).
Girometti R et al . CEUS in patients with renal failure
15 January 28, 2017|Volume 9|Issue 1|WJR|www.wjgnet.com
exposure or the use of nephrotoxic contrast agents. 
When renal lesions were identified in patients with renal 
failure, CEUS was able to discriminate between solid 
and cystic ones, as well as to categorize cysts according 
to the Bosniak criteria. Characterizing lesions with 
indeterminate appearance on conventional US modes 
as a presumably benign cysts prevented unnecessary 
operations in patients with renal failure (usually poor 
surgical candidates with high risk of complications), and 
further deterioration of the renal function.
Though cost-effectiveness analysis was beyond the 
purpose of this study, one can reasonably assume that 
evaluating the above patients with CEUS would led 
to prompt diagnosis and treatment while minimizing 
patients’ risk and costs compared to conventional diag-
nostic strategy combining US and CT/MRI (including 
related complications). One might argue that the use 
of CEUS is often limited to experienced centers, and 
no randomized controlled trials support the above 
statements. However, the experience acquired in re-
ference centres and guidelines recommendations (e.g., 
EFSUMB ones) are now promoting an ever-increasing 
and widespread use of CEUS, as exemplified by extended 
indications to paediatric population[1]. We also believe 
that our study results might contribute as a reference 
for the planning of future studies designed to obtain 
high-level evidence in large populations with normal or 
impaired renal function. Potential effectiveness of CEUS 
diagnosis is further emphasized by the fact that this 
technique can be performed at patients’ bedside, which 
is of special advantage for critically ill ones.
This study has several limitations. The most im-
portant one is that the gold standard investigation has 
not been obtained for the majority of patients with 
renal function deterioration. Because of the concern 
for further deterioration of renal function, no additional 
imaging modalities were performed when the results 
of CEUS and clinical features were found sufficient for 
patient’s work-up. Only a limited number of patients 
with suspicious perfusion abnormalities had kidney 
biopsy (3/50 patients). As a consequence, causative 
diagnosis for renal function deterioration remained 
indeterminate in 5 patients with CEUS findings 
suggestive for renal infarction and 12 patients without 
CEUS evidence of vascular abnormalities. Gold standard 
investigation was not available also for 25/41 renal 
masses (8/21 solid lesions and 17/20 cysts), whereas 
12 patients with presumably malignant renal lesions 
(7 solid indeterminate lesions, 1 inoperable solid lesion 
and 4 Bosniak Ⅲ-Ⅳ cysts) were not operated because 
the surgical risk was considered excessive due to 
comorbidities. However, all operated or ablated lesions 
(n = 15) were found to have cancer at histological 
examination, thus emphasizing the effectiveness of 
CEUS in guiding most proper treatment. 
Another major limitation of the present study is its 
retrospective design. This might have introduced a case-
selection bias, because some cases may have not been 
recorded for inclusion. Additionally, a relatively small 
number of lesions have been evaluated, reflecting the 
fact that CEUS has been performed as a problem solving 
technique to assess very specific diagnostic questions.
Finally, in our series CEUS failed to detect perfusion 
abnormalities in patients with atheroembolic renal 
disease. We can only speculate on the anatomic basis 
for this finding: atheroembolic renal disease consists in 
patchy embolization of very small arteries (interlobular 
and afferent arterioles) by cholesterol crystals resulting 
in cortical ischemic areas which are likely too small to be 
detected with imaging methods.
In conclusion, our study shows that CEUS has a 
significant role as a problem-solving technique for de-
tection of perfusion abnormalities and characterization of 
renal lesions in patients with renal failure. CEUS can be 
performed in emergency at the bedside. In our series, it 
was helpful in stratifying treatment decisions, as shown 
by the fact that all patients with suspicious renal cancer 
in whom surgery was not contraindicated were operated 
properly.
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Background
Imaging in patients with acute or chronic renal function impairment (RFI) is 
challenging because of nephrotoxicity or the risk for nephrogenic systemic 
fibrosis (NSF) related to the use of computed tomography (CT) and magnetic 
Figure 5  Patient with grade III chronic renal 
failure that one category IV lesion was a clear 
cell renal cell carcinoma at nephrectomy. A: Grey-
scale ultrasound showed a complex renal lesion 
(arrow); B: Contrast enhanced ultrasound showed 
thickened wall with a vegetation (1) consistent for a 
presumably malignant, Bosniak category IV lesion. A 
clear cell renal cell carcinoma was found at surgery.
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resonance imaging contrast agents, respectively. Contrast-enhanced ultrasound 
(CEUS) is gaining widespread acceptance as the imaging modality of choice 
to evaluate patients with RFI, given the absence nephrotoxicity and the ability 
of representing renal vascularization with excellent sensitivity and high spatial 
resolution. However, the consensus on its use in this setting is related more 
to experts’ opinion and clinical practice than specifically addressed studies. 
Hence, evidence on this topic still lacks as a basis to support clinical practice 
and future trials.
Research frontiers
CEUS has a pivotal role in assessing patients with RFI. However, despite the 
use of CEUS in this scenario, there is paucity of scientific evidence supporting 
it. The results of the study show that CEUS has a significant impact in managing 
patients with RFI and might contribute to strengthen the recommendation to use 
it as the imaging method of choice in this setting.
Innovations and breakthroughs
The authors provided an evidence-based background for supporting the use of 
CEUS in patients with RFI. CEUS is safer than contrast-enhanced computed 
tomography and/or magnetic resonance imaging in evaluating patients with RFI. 
This technique can be performed on patients’ bedside, thus allowing prompt 
diagnosis and management. 
Applications
Their study shows that CEUS is a problem-solving technique in detecting 
perfusion abnormalities and characterizing renal lesions in patients with renal 
failure.
Terminology
CEUS: An ultrasound technique using microbubble contrast agents.
Peer-review
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